Alec has collaborated extensively with global life sciences innovators, leading strategic engagements across product and organizational life cycles. While Alec has tackled a diverse range of business problems, areas of particular focus include platform growth strategy, corporate strategy (asset and therapeutic area), and business development, both for biopharma and investors. In that context, Alec has deep experience across major therapeutic areas, with recent emphasis in neurology, oncology/hematology, orphan diseases, and immunology. When partnering with clients, Alec strives to bridge technical/clinical perspectives to clear business implications for organizations, and articulate realistic paths forward.
Alec has 6+ years of experience in life sciences consulting and research. Alec holds an MBA from MIT Sloan and B.A.s in Neuroscience and Economics from Dartmouth College.
Debbi Amanti Belanger